160662-16-8

Basic information

• Product Name: (LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG)
• Synonyms: CYCLO(-ARG-LYS-PRO-TRP-GLU)-LEU-OH;(LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG)
• CAS NO: 160662-16-8
• Molecular Formula: C39H59N11O8
• Molecular Weight: 809.95
• Mol File: 160662-16-8.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• Storage Temp.: -15°C
• CAS DataBase Reference: (LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG)(CAS DataBase Reference)
• NIST Chemistry Reference: (LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG)(160662-16-8)
• EPA Substance Registry System: (LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG)(160662-16-8)

Safety Data

• Hazardous Substances Data: 160662-16-8(Hazardous Substances Data)

Usage

General Description

(LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG) is a synthetic cyclic analog of the neuropeptide neurotensin, consisting of the amino acid sequence Lysine 9, Tryptophan 11, and Glutamate 12. Neurotensin is known to regulate a variety of physiological functions including neurotransmission, cardiovascular function, and pain modulation. The (LYS9,TRP11,GLU12)-NEUROTENSIN (8-13) (CYCLIC ANALOG) has been studied for its potential in modulating neurotensin receptors and its actions on the central nervous system. It is being investigated for its potential therapeutic applications in conditions such as schizophrenia, Parkinson's disease, and obesity. This cyclic analog is being explored for its ability to enhance the bioavailability and stability of neurotensin, and its potential as a novel drug candidate for various neurological and metabolic disorders.